FlowIntell
PrivateLast Round
Grant
Mar 1, 2024
Total Funding Raised
$93,000
Company Overview
FlowIntell is a biotechnology company that develops non-invasive, at-home diagnostic screening kits for endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Telemedicine, Patient Engagement
Business Model
B2C
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FlowIntell Comparables
Compare FlowIntell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diamens | 82% | |
| NextGen Jane | 79% | |
| DotLab | 77% | |
FlowIntell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2024 | ||||
| SAFE | Feb 1, 2024 | ||||
| Grant | Sep 1, 2023 |
FlowIntell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Crummer Venture Plan Competition | Grant |
| Camelback Ventures | SAFE |
| Startup Runway Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2024
$40K raised from Crummer Venture Plan Competition
FlowIntell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FlowIntell's valuation, stock price, and market status.